[New onset of atrial fibrillation--rate or rhythm control?].
Lewalter
T
T
Klinik II, St.Vincenz-Krankenhaus Paderborn, Universität Göttingen, Paderborn. t.lewalter@vincenz.de
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004554:Electric Countershock; D004562:Electrocardiography / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D020766:Intracranial Embolism / Q000517:prevention & control; D012008:Recurrence
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants